CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Company Registration Number:
12310198 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 December 2022

End date: 30 November 2023

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Contents of the Financial Statements

for the Period Ended 30 November 2023

Company Information - 3
Report of the Directors - 4
Income and Expenditure Account - 5
Balance sheet - 6
Additional notes - 8

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Company Information

for the Period Ended 30 November 2023




Director: Yolande Borthwick
Anita Hobday
Cheryl Pike
Rhian Noble-Jones
Jacqueline Banks
Jeanne Everett
Lynne Whiteside
Registered office: 3 Llwyngwern
Hendy
Swansea
GB-WLS
SA4 0AB
Company Registration Number: 12310198 (England and Wales)

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Directors' Report Period Ended 30 November 2023

The directors present their report with the financial statements of the company for the period ended 30 November 2023

Principal Activities

Raise awareness and education of Lymphoedema to Health Care Professionals

Political and charitable donations

N/A

Company policy on the employment of disabled persons

N/A - no employees

Directors

The director(s) shown below were appointed to the company during the period
Yolande Borthwick
01 December 2022
Anita Hobday
01 December 2022
Cheryl Pike
01 December 2022
Rhian Noble-Jones
01 December 2022
Jacqueline Banks
01 December 2022
Jeanne Everett
01 December 2022
Lynne Whiteside
01 December 2022

This report was approved by the board of directors on 25 August 2024
And Signed On Behalf Of The Board By:

Name: Cheryl Pike
Status: Director

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Income and Expenditure Account

for the Period Ended 30 November 2023


Notes

2023
£

2022
£
Turnover 0 0
Cost of sales ( 2,909 ) ( 528 )
Gross surplus or (deficit) ( 2,909 ) ( 528 )
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 637 ) ( 883 )
Other operating income 0 0
Operating surplus or (deficit) ( 3,546 ) ( 1,411 )
Interest Receivable and Similar Income 0 0
Surplus or (deficit) before tax ( 3,546 ) ( 1,411 )
Tax on surplus ( 0 ) ( 0 )
Surplus or (deficit) for the period ( 3,546 ) ( 1,411 )

The notes form part of these financial statements

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Balance sheet

As at 30 November 2023


Notes

2023
£

2022
£
Fixed assets
Total fixed assets: - -
Current assets
Cash at bank and in hand: 11,656 16,066
Total current assets: 11,656 16,066
Net current assets (liabilities): 11,656 16,066
Total assets less current liabilities: 11,656 16,066
Total net assets (liabilities): 11,656 16,066

The notes form part of these financial statements

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Balance sheet continued

As at 30 November 2023


Notes

2023
£

2022
£
Reserves
Income and expenditure account 11,656 16,066
Members funds 11,656 16,066

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 25 August 2024
And Signed On Behalf Of The Board By:

Name: Cheryl Pike
Status: Director

The notes form part of these financial statements

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 0 0

CASLEY-SMITH LYMPHOEDEMA EDUCATION UK LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 3. Off balance sheet disclosure

    No